Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Transplantation | 4 | 2020 | 389 | 1.220 |
Why?
|
| Asthma | 6 | 2021 | 891 | 1.040 |
Why?
|
| Energy Metabolism | 4 | 2016 | 1005 | 0.880 |
Why?
|
| Arginine | 4 | 2016 | 509 | 0.830 |
Why?
|
| Citrulline | 3 | 2015 | 112 | 0.810 |
Why?
|
| Fungi | 2 | 2021 | 148 | 0.800 |
Why?
|
| Allergens | 2 | 2021 | 252 | 0.760 |
Why?
|
| Transplant Recipients | 2 | 2021 | 337 | 0.730 |
Why?
|
| Nitric Oxide | 4 | 2015 | 664 | 0.680 |
Why?
|
| Fibrinolysis | 1 | 2019 | 47 | 0.670 |
Why?
|
| Burnout, Professional | 1 | 2023 | 227 | 0.660 |
Why?
|
| Tacrolimus | 1 | 2020 | 351 | 0.640 |
Why?
|
| Pleura | 1 | 2019 | 129 | 0.620 |
Why?
|
| Drug Monitoring | 1 | 2020 | 356 | 0.610 |
Why?
|
| Shock, Septic | 2 | 2009 | 186 | 0.580 |
Why?
|
| Pleural Effusion | 1 | 2019 | 219 | 0.570 |
Why?
|
| Surgeons | 1 | 2023 | 484 | 0.560 |
Why?
|
| Catheterization | 1 | 2019 | 423 | 0.560 |
Why?
|
| Drainage | 1 | 2019 | 448 | 0.550 |
Why?
|
| Immunity, Innate | 1 | 2021 | 688 | 0.540 |
Why?
|
| Graft Rejection | 1 | 2020 | 865 | 0.520 |
Why?
|
| Sepsis | 2 | 2013 | 689 | 0.510 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1050 | 0.480 |
Why?
|
| Nutritional Requirements | 1 | 2015 | 186 | 0.460 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 749 | 0.440 |
Why?
|
| Weight Gain | 1 | 2016 | 475 | 0.440 |
Why?
|
| Enterocytes | 1 | 2013 | 77 | 0.420 |
Why?
|
| Rest | 1 | 2011 | 68 | 0.380 |
Why?
|
| Glutamine | 1 | 2013 | 329 | 0.370 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 4385 | 0.370 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 134 | 0.350 |
Why?
|
| Tuberculosis | 1 | 2016 | 617 | 0.340 |
Why?
|
| Glucose | 2 | 2011 | 1249 | 0.310 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 331 | 0.300 |
Why?
|
| Carbon Isotopes | 3 | 2015 | 370 | 0.280 |
Why?
|
| Models, Biological | 1 | 2015 | 3225 | 0.270 |
Why?
|
| Proteins | 2 | 2011 | 2047 | 0.260 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 583 | 0.250 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2018 | 117 | 0.250 |
Why?
|
| Leucine | 3 | 2013 | 381 | 0.240 |
Why?
|
| Th2 Cells | 3 | 2021 | 253 | 0.240 |
Why?
|
| Nitrogen Isotopes | 2 | 2015 | 64 | 0.240 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 454 | 0.230 |
Why?
|
| Depersonalization | 1 | 2023 | 14 | 0.220 |
Why?
|
| Antigens, Fungal | 1 | 2021 | 44 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 39688 | 0.180 |
Why?
|
| Female | 18 | 2021 | 148467 | 0.180 |
Why?
|
| Middle Aged | 12 | 2020 | 90016 | 0.170 |
Why?
|
| Warfarin | 1 | 2021 | 152 | 0.170 |
Why?
|
| Male | 15 | 2021 | 128412 | 0.170 |
Why?
|
| Humans | 23 | 2023 | 270856 | 0.170 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2018 | 10 | 0.150 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2018 | 21 | 0.150 |
Why?
|
| Pectoralis Muscles | 1 | 2017 | 25 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2021 | 1619 | 0.140 |
Why?
|
| Pulmonary Atelectasis | 1 | 2017 | 51 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 320 | 0.140 |
Why?
|
| Adult | 12 | 2020 | 81545 | 0.130 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2017 | 94 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2021 | 1269 | 0.130 |
Why?
|
| Indicator Dilution Techniques | 1 | 2015 | 24 | 0.130 |
Why?
|
| Jamaica | 1 | 2015 | 27 | 0.130 |
Why?
|
| Isotopes | 1 | 2015 | 36 | 0.130 |
Why?
|
| Ornithine | 1 | 2015 | 42 | 0.130 |
Why?
|
| Demography | 1 | 2016 | 435 | 0.120 |
Why?
|
| Acute Disease | 1 | 2020 | 2515 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2021 | 785 | 0.120 |
Why?
|
| Deuterium | 1 | 2015 | 110 | 0.120 |
Why?
|
| Exhalation | 1 | 2015 | 61 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2015 | 167 | 0.120 |
Why?
|
| Meals | 1 | 2015 | 64 | 0.120 |
Why?
|
| India | 1 | 2015 | 314 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 144 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 4503 | 0.110 |
Why?
|
| Splanchnic Circulation | 1 | 2013 | 58 | 0.110 |
Why?
|
| Lung | 2 | 2021 | 3267 | 0.100 |
Why?
|
| Body Composition | 1 | 2015 | 609 | 0.100 |
Why?
|
| Radioactive Tracers | 1 | 2011 | 31 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2017 | 751 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2011 | 6027 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 5899 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2018 | 1201 | 0.090 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2010 | 80 | 0.090 |
Why?
|
| Breath Tests | 1 | 2010 | 201 | 0.080 |
Why?
|
| Mitochondria | 1 | 2016 | 1318 | 0.080 |
Why?
|
| Aged | 5 | 2020 | 73160 | 0.080 |
Why?
|
| Glycolysis | 1 | 2011 | 533 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 1438 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2399 | 0.070 |
Why?
|
| Biomarkers | 3 | 2018 | 5105 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 1124 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 15247 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 241 | 0.070 |
Why?
|
| Prognosis | 3 | 2019 | 22456 | 0.070 |
Why?
|
| Kinetics | 1 | 2009 | 2246 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 2465 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5435 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 960 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 6413 | 0.060 |
Why?
|
| Quality of Life | 1 | 2017 | 4731 | 0.050 |
Why?
|
| Liver | 1 | 2013 | 3124 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2018 | 12205 | 0.040 |
Why?
|
| United States | 1 | 2016 | 15981 | 0.040 |
Why?
|
| Algorithms | 1 | 2010 | 3908 | 0.040 |
Why?
|
| Pregnancy | 1 | 2010 | 8042 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 2526 | 0.040 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2016 | 49 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 182 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 66 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 67 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2016 | 130 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 989 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 255 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 837 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 257 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2017 | 812 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 2288 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 2048 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2016 | 741 | 0.020 |
Why?
|
| Adolescent | 2 | 2010 | 32556 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2430 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 150 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 3417 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4983 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 30941 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 1153 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 5492 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 4985 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2010 | 272 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 2199 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2008 | 33819 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6890 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 6464 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 2191 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 6832 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 9430 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12516 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 2237 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 7783 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17820 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2940 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 35990 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 62759 | 0.010 |
Why?
|